Status In progress
Technology type Device
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
ID number 1
Description Aortic stenosis occurs when the aortic valve, which separates the main pumping chamber of the heart from the circulation, becomes narrowed. This may reduce the flow of blood out of the heart, causing pain and breathlessness. In order to reduce symptoms and prolong life, the aortic valve may need to be replaced with a prosthetic valve during open heart surgery. Trans Catheter insertion of a new aortic valve (a procedure called ‘transcatheter aortic valve implantation’ or TAVI for short) may be an alternative to surgical valve replacement. The procedure is performed through a tube or catheter, which is usually inserted into a large blood vessel, usually at the top of the leg but maybe elsewhere, or directly into the apex of the heart through the chest wall. A replacement valve is inserted through this tube and placed within the existing faulty valve, which is squashed to make room for the new valve.

Project Team

Project lead Bruce Smith

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
12 March 2025 Update post-resolution period. NICE has a resolution process that acts as a final quality-assurance step to ensure that NICE acts fairly, follows its own processes, and produces clear, accurate guidance. Please see section 7.2 in NICE's health technology manual for more detail on this process. A resolution panel has been held. A resolution request on breach of process was upheld regarding the wording of the recommendation. The panel recommended reconvening committee to reconsider the relevance of NG208 to cross-reference cost-effectiveness thresholds and the determination of value for money in this LSA. The panel also concluded that the reconvened committee should review the approach to searching for and selecting evidence in this LSA. We are currently looking at the schedule and will be in touch soon regarding the date of this committee, and key steps leading up to it.
08 January 2025 Publication delay. The resolution period has ended and NICE has received resolution requests. Therefore guidance publication will be suspended while the requests are reviewed via the resolution process.
17 October 2024 Committee meeting: 2
09 August 2024 - 02 September 2024 Diagnostics consultation
18 July 2024 Committee meeting: 1
19 April 2024 To allow the External Assessment Group (EAG) additional time to finalise their report and to ensure feedback from the consultation on the process and methods has been taken into consideration, the committee discussion that was scheduled to take place on 16 May 2024 will be cancelled. The revised timelines for the assessment will be published on the webpage in due course
08 December 2023 Scope published
30 November 2023 Scoping workshop
17 October 2023 In progress. Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
13 October 2023 Awaiting development. Status change linked to Topic Selection Decision being set to Selected